Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula

IF 9.1 1区 医学 Q1 ONCOLOGY Cancer letters Pub Date : 2024-08-27 DOI:10.1016/j.canlet.2024.217198
Wei-Jan Wang , Hsuan-Ting Tang , Shi-Chen Ou , Wan-Jou Shen , Chung-Yu Chen , Yi-Chuan Li , Sui-Yuan Chang , Wei-Chao Chang , Po-Ren Hsueh , Sheng-Teng Huang , Mien-Chie Hung
{"title":"Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula","authors":"Wei-Jan Wang ,&nbsp;Hsuan-Ting Tang ,&nbsp;Shi-Chen Ou ,&nbsp;Wan-Jou Shen ,&nbsp;Chung-Yu Chen ,&nbsp;Yi-Chuan Li ,&nbsp;Sui-Yuan Chang ,&nbsp;Wei-Chao Chang ,&nbsp;Po-Ren Hsueh ,&nbsp;Sheng-Teng Huang ,&nbsp;Mien-Chie Hung","doi":"10.1016/j.canlet.2024.217198","DOIUrl":null,"url":null,"abstract":"<div><div>The ongoing COVID-19 pandemic is a persistent challenge, with continued breakthrough infections despite vaccination efforts. This has spurred interest in alternative preventive measures, including dietary and herbal interventions. Previous research has demonstrated that herbal medicines can not only inhibit cancer progression but also combat viral infections, including COVID-19 by targeting SARS-CoV-2, indicating a multifaceted potential to address both viruses and cancer. Here, we found that the Kang Guan Recipe (KGR), a novel herbal medicine formula, associates with potent inhibition activity against the SARS-CoV-2 viral infection. We demonstrate that KGR exhibits inhibitory activity against several SARS-CoV-2 variants of concern (VOCs). Mechanistically, we found that KGR can block the interaction of the viral spike and human angiotensin-converting enzyme 2 (ACE2). Furthermore, we assessed the inhibitory effect of KGR on SARS-CoV-2 viral entry in vivo, observing that serum samples from healthy human subjects having taken KGR exhibited suppressive activity against SARS-CoV-2 variants. Our investigation provides valuable insights into the potential of KGR as a novel herbal-based preventive and therapeutic strategy against COVID-19.</div></div>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"604 ","pages":"Article 217198"},"PeriodicalIF":9.1000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383524005937","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The ongoing COVID-19 pandemic is a persistent challenge, with continued breakthrough infections despite vaccination efforts. This has spurred interest in alternative preventive measures, including dietary and herbal interventions. Previous research has demonstrated that herbal medicines can not only inhibit cancer progression but also combat viral infections, including COVID-19 by targeting SARS-CoV-2, indicating a multifaceted potential to address both viruses and cancer. Here, we found that the Kang Guan Recipe (KGR), a novel herbal medicine formula, associates with potent inhibition activity against the SARS-CoV-2 viral infection. We demonstrate that KGR exhibits inhibitory activity against several SARS-CoV-2 variants of concern (VOCs). Mechanistically, we found that KGR can block the interaction of the viral spike and human angiotensin-converting enzyme 2 (ACE2). Furthermore, we assessed the inhibitory effect of KGR on SARS-CoV-2 viral entry in vivo, observing that serum samples from healthy human subjects having taken KGR exhibited suppressive activity against SARS-CoV-2 variants. Our investigation provides valuable insights into the potential of KGR as a novel herbal-based preventive and therapeutic strategy against COVID-19.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗癌中药配方《康冠方》的新型 SARS-CoV-2 抑制特性
目前的 COVID-19 大流行是一项持久性挑战,尽管疫苗接种工作取得了进展,但仍不断出现突破性感染。这激发了人们对替代性预防措施的兴趣,包括饮食和草药干预。以往的研究表明,中草药不仅能抑制癌症进展,还能通过靶向 SARS-CoV-2 抗击包括 COVID-19 在内的病毒感染,这表明中草药具有同时应对病毒和癌症的多方面潜力。在这里,我们发现一种新型中药配方--《康冠秘方》(KGR)对 SARS-CoV-2 病毒感染具有强效抑制活性。我们证明,KGR 对几种 SARS-CoV-2 变异病毒(VOCs)具有抑制活性。从机理上讲,我们发现 KGR 可以阻断病毒尖峰与人类血管紧张素转换酶 2(ACE2)的相互作用。此外,我们还评估了KGR对体内SARS-CoV-2病毒进入的抑制作用,观察到服用KGR的健康人血清样本对SARS-CoV-2变体具有抑制活性。我们的研究为KGR作为一种新型草药预防和治疗COVID-19的潜力提供了宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer letters
Cancer letters 医学-肿瘤学
CiteScore
17.70
自引率
2.10%
发文量
427
审稿时长
15 days
期刊介绍: Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research. Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy. By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.
期刊最新文献
Editorial Board Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283]. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Nuclear Factor I/B: Duality in Action in Cancer Pathophysiology. Local ablation disrupts immune evasion in pancreatic cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1